首页> 外文期刊>Clinical and vaccine immunology: CVI >Regional immune response to immunization with escherichia coli O157:H7-derived intimin in cattle
【24h】

Regional immune response to immunization with escherichia coli O157:H7-derived intimin in cattle

机译:大肠杆菌O157对免疫的区域免疫反应:H7衍生的牛蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

Escherichia coli O157:H7 is an enteric pathogen of animals and humans that can result in deadly sequelae. Cattle are asymptomatic carriers and shedders of the bacteria and serve as an important reservoir of human infection. E. coli O157:H7 colonizes the gastrointestinal tract, most frequently at the rectoanal junction mucosa in cattle. Vaccination is a potentially highly effective means of decreasing cattle colonization and shedding and thereby decreasing human infections. Currently available vaccines are administered subcutaneously or intramuscularly, and immune responses have been evaluated solely by systemic immunoglobulin responses. This study evaluated local and systemic lymphoproliferative responses in addition to immunoglobulin responses following subcutaneous or mucosal (rectal) immunization with E. coli O157:H7 outer membrane protein intimin over three trials. In all three trials, significant local and systemic lymphoproliferative responses (P<0.05) occurred following immunization in the majority of animals, as well as significant immunoglobulin responses (P<0.001) in all animals. Surprisingly, local responses in the mesorectal lymph nodes were very similar between the subcutaneous and mucosal immunization groups. Moreover, the responses in mesorectal lymph nodes appeared targeted rather than generalized, as minimal or no significant responses were observed in the associated prescapular lymph nodes of subcutaneously immunized animals. The results indicate that both subcutaneous and mucosal immunizations are effective methods of inducing immune responses against E. coli O157:H7 in cattle.
机译:大肠杆菌O157:H7是动物和人类的肠病,可能导致致命的后遗症。牛是细菌的无症状携带者和棚子,是人类感染的重要储层。大肠杆菌O157:H7在牛的直肠连接粘膜上最常殖民地胃肠道。疫苗接种是减少牛定植和脱落并从而减少人类感染的潜在高效手段。当前可用的疫苗是皮下或肌肉内给药的,并且免疫反应仅通过全身免疫球蛋白反应来评估。这项研究还评估了皮下或粘膜(直肠)免疫(直肠)免疫(直肠)免疫的局部和全身性淋巴增生反应,并在三个试验中对大肠杆菌O157:H7外膜蛋白质素进行了外膜蛋白质素。在所有三项试验中,大多数动物免疫后发生了明显的局部和全身性淋巴增生反应(P <0.05),以及所有动物的显着免疫球蛋白反应(P <0.001)。令人惊讶的是,皮下和粘膜免疫组之间介直直肠淋巴结的局部反应非常相似。此外,由于皮下免疫免疫的动物的相关前副预性淋巴结中,伴有最小或没有明显的反应似乎是针对性的,而不是普遍的,因此伴有诊断淋巴结的反应是有针对性的。结果表明,皮下和粘膜免疫都是在牛中诱导针对大肠杆菌O157:H7的免疫反应的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号